BEVACIZUMAB (BV) IN COMBINATION WITH FOLFOXIRI COMPARED TO BV PLUS FOLFIRI AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC): PRELIMINARY SAFETY RESULTS OF THE TRIBE STUDY BY THE GRUPPO ONCOLOGICO NORD-OVEST (GONO)

ANNALS OF ONCOLOGY(2010)

引用 0|浏览15
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要